BamSEC and AlphaSense Join Forces
Learn More

Traws Pharma Inc. – Material Contracts

NASDAQ: TRAW    
Share price (3/26/26): $1.93    
Market cap (3/26/26): $15.4 million

Material Contracts Filter

EX-10.1
from 8-K 15 pages Traws Pharma, Inc. 2021 Incentive Compensation Plan
12/34/56
EX-10.1
from 8-K 19 pages Asset Purchase Agreement
12/34/56
EX-10.1
from 8-K 15 pages Traws Pharma, Inc. Employment Agreement
12/34/56
EX-10.47
from 10-K 9 pages Consulting Services Agreement
12/34/56
EX-10.46
from 10-K 9 pages Separation Agreement and Release of All Claims
12/34/56
EX-10.36
from 10-K 10 pages License Agreement
12/34/56
EX-10.34
from 10-K 13 pages ​ Master Research and Development Agreement
12/34/56
EX-10.33
from 10-K 12 pages Master Research and Development Agreement
12/34/56
EX-10.31
from 10-K 11 pages Master Research and Development Agreement
12/34/56
EX-10.1
from 8-K 44 pages At the Market Offering Agreement Up to $50,000,000 Shares of Common Stock
12/34/56
EX-10.2
from 8-K 3 pages February 5, 2025 Job Classification: Full-Time Flsa Classification: Exempt
12/34/56
EX-10.1
from 8-K 12 pages Separation Agreement and Release of All Claims
12/34/56
EX-10.2
from 8-K 8 pages Form of Company Stockholder Support Agreement Traws Pharma, Inc. Support Agreement
12/34/56
EX-10.1
from 8-K 28 pages Form of Securities Purchase Agreement
12/34/56
EX-10.5
from 10-Q 16 pages ​ Traws Pharma, Inc. ​ Employment Agreement
12/34/56
EX-10.4
from DEFA14A 3 pages Title: Flsa Classification: Exempt
12/34/56
EX-10.4
from 8-K 3 pages Title: Flsa Classification: Exempt
12/34/56
EX-10.3
from DEFA14A 17 pages Onconova Therapeutics, Inc. Employment Agreement
12/34/56
EX-10.3
from 8-K 17 pages Onconova Therapeutics, Inc. Employment Agreement
12/34/56
EX-10.2
from DEFA14A 28 pages Registration Rights Agreement
12/34/56